How to determine the optimal treatment timing in chronic HBV infection patients with normal ALT and positive HBeAg?

Hong ZHAO; Wen XIE

doi:10.3969/j.issn.1001-5256.2021.06.012

Volume 37 Issue 6

Jun. 2021

Turn off MathJax

Article Contents

Article Navigation > Journal of Clinical Hepatology > 2021 > 37(6): 1281-1281

PDF( 1760 KB)

How to determine the optimal treatment timing in chronic HBV infection patients with normal ALT and positive HBeAg?

DOI: 10.3969/j.issn.1001-5256.2021.06.012

Hong ZHAO,
Wen XIE^,

Liver Disease Center, Beijing Ditan Hospital, Capital Medical University, Beijing 100015, China

Received Date: 2021-03-31
Accepted Date: 2021-03-31
Published Date: 2021-06-20

Abstract

- Hepatitis B Virus,
- Hepatitis B, Chronic,
- Immune Tolerance,
- Therapeutics

FullText(HTML)

References(4)

References

[1]	CHEN CJ, YANG HI, SU J, et al. Risk of hepatocellular carcinoma across a biological gradient of serum hepatitis B virus DNA level[J]. JAMA, 2006, 295(1): 65-73. DOI: 10.1001/jama.295.1.65.
[2]	KIM GA, LIM YS, HAN S, et al. High risk of hepatocellular carcinoma and death in patients with immune-tolerant-phase chronic hepatitis B[J]. Gut, 2018, 67(5): 945-952. DOI: 10.1136/gutjnl-2017-314904.
[3]	LEE HW, KIM EH, LEE J, et al. Natural history of untreated HBeAg-positive chronic HBV infection with persistently elevated HBV DNA but normal alanine aminotransferase[J]. Clin Transl Gastroenterol, 2020, 11(3): e00140. DOI: 10.14309/ctg.0000000000000140.
[4]	CHANG Y, CHOE WH, SINN DH, et al. Nucleos(t)ide analogue treatment for patients with hepatitis B virus (HBV) e antigen-positive chronic HBV genotype C infection: A nationwide, multicenter, retrospective study[J]. J Infect Dis, 2017, 216(11): 1407-1414. DOI: 10.1093/infdis/jix506.

Relative Articles

Supplements(0)

Cited By

Proportional views

Proportional views

通讯作者: 陈斌, bchen63@163.com

1.
沈阳化工大学材料科学与工程学院沈阳 110142

Get Citation

PDF

XML

Article Metrics

Article views (308) PDF downloads(84)

How to determine the optimal treatment timing in chronic HBV infection patients with normal ALT and positive HBeAg?

DOI: 10.3969/j.issn.1001-5256.2021.06.012

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

How to determine the optimal treatment timing in chronic HBV infection patients with normal ALT and positive HBeAg?

DOI: 10.3969/j.issn.1001-5256.2021.06.012

References

Proportional views

Catalog

通讯作者: 陈斌, bchen63@163.com

Article Metrics

Proportional views

Related

About Journal

Submission Guideline

Journal Online

Hepatobiliary College

Guidelines

Export File

Citation

Format

Content